At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
KTP laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Evaluation of the Treatment of Spider Angioma Using a Dual Wavelength Laser Emitting 532 nm Laser Energy
In Brief
A clinical study evaluating KTP laser for Spider Angioma. Completed, enrolled 22 participants across 1 site.
Detailed Summary
To evaluate the safety and effectiveness of the laser treatment for the treatment of spider angiomas.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpider Angioma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartMay 2016
Primary CompletionJan 2017
Study CompletionApr 2017
TodayJul 2026
First PostedApr 29, 2016
Enrollment StartMay 26, 2016
Primary CompletionJan 13, 2017
Study CompletionApr 4, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.2 years ago
Interventions
KTP laserdevice
Dual Wavelength Laser Emitting 532 nm Laser Energy